Genocea Biosciences reported $-15773000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -44972000 8.98M
Baxter International BAX:US $ 432M 99M
Bluebird Bio BLUE:US $ -100761000 19.58M
Cytokinetics CYTK:US $ -10874000 66.98M
Cytori Therapeutics CYTX:US $ -5120000 1.19M
Genocea Biosciences GNCA:US $ -15773000 2.36M
Glaxosmithkline GSK:US 1.82B 600M
Infinity Pharmaceuticals INFI:US -12018000 389K
Merk MRK:US $ 5711M 652M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Pfizer PFE:US $ 12099M 2104M
Prothena PRTA:US -43209000 5.26M